Categories: India

IIL started the supply of covaxin medicine to Bio Bio for 3-4 million doses per month

Hyderabad: In the movement that will soon increase the production capacity of Covid-19 Covaxin developed by the original, Immunologicals Ltd (IIL) on Friday handed the first batch of covax medicine to Bharat Biotech.
While to start with IIL will supply drug substances around 3 to 4 million per month, from December, this will increase up to 10 million doses per month, Iil Director of Implementing Dr.
K Anand Kumar said on the opportunity to handle first of the covaxin drug Bharat Biotech Chairman and Managing Director Dr.
Krishna Ella with a simple attack on the ceremony.
IIL and Bharat Biotech have signed an agreement for the same thing on April 2021 after that IIL transmits the BSL-2 facility + manufacturing anti-rabies vaccine in Karakapatla in Genome Valley.
IIL, which signed four agreements with Bharat Biotech, able to reuse its manufacturing facilities in Hyderabad, get raw materials and consumables and key equipment for processes, technology transfers, trials on the R & D scale, training and training in time and production training Started in July 2021.
“The batch produced in IIL manufacturing facilities has been tested in BBIL and IIL and meets quality specifications for medicine.
The results are more than expected,” said Dr.
Anand Kumar.
“This is an Indian team at work.
It is not possible without coming along with several shareholders to achieve a common goal.
Our capable and competent team works tirelessly all the time to ensure that the schedule that is committed and the quality of the product is fulfilled.” “This is a moment which boasts for IIL to play an important role in supporting the interests of our nation during an unprecedented time.
This will not be possible without constant support provided by Niti-Aayog, BIRAC, DBT, Mission Covid Surakha Tim, Central and County Narcotics Control Drugs , “he added.
Dr.
Renu Swarup, Secretary of DBT and Chair of BIRAC said, “Liberal License Agreement by CDSCO for Immunology India Ltd.
to produce covaxin drugs is a major milestone, achieved in a very short time span.
DBT-BIRAC support under the Mission Covid Surakha aims to meet Our Covid-19 Vaccine needs.
“IIL approved Hospital 60 Crore grants to improve production capabilities as part of the Surakha Covid mission.
In addition to producing covaxin drug substances, IIL also working on the Covid-19 vaccine itself which is currently undergoing an ongoing animal trial with the expected vaccine ready for human vaccination next year, said Dr.
Anand Kumar.

news2in

Share
Published by
news2in

Recent Posts

44 ordered to attack the procession

Ludhiana: The police have submitted FIR to four identified and at least 40 unknown attackers…

3 years ago

Punjab: Police Reject conspiracy theory in the case of Deep Sidhu

Sonīpat / Ludhiana / Ambala: Actor Punjabi - Activist Activist Deep Sidhu, who died in…

3 years ago

Punjab: Hidden Strength Working Behind PM Narendra Modi, Arvind Kejriwal, said Rahul Gandhi

PATIALA / MANSA / BARNALA: Attacking Prime Minister Narendra Modi and AAP National Convener Kejriawal,…

3 years ago

BJP made AAP to endanger the Congress, said Ajay

Jalandhar: BJP and AAM AAM AADMI parties are one party, Secretary General of the Ajay…

3 years ago

Our job is to make Punjab No. 1 State: Meenakshi Lekhi

Ludhiana: Minister of Union Culture Meenakshi Lekhi while campaigning to support the BJP candidate from…

3 years ago

Feb 20 is an opportunity to change the destiny of Punjab and his children: Bhagwant Mann

Machhiwara (Ludhiana): AAM AAM AADMI Party (AAP) Head of Punjab Candidate and Members of Parliament…

3 years ago